Granisetron primarily functions as a serotonin 5-HT3 receptor antagonist, exerting its antiemetic effects by blocking the action of serotonin at these receptors. By antagonizing the 5-HT3 receptors, granisetron inhibits serotonin-mediated signaling that contributes to nausea and vomiting. Unlike some other antiemetic drugs, granisetron does not directly affect dopamine receptors (as seen with dopamine receptor antagonists like metoclopramide) or muscarinic receptors (as seen with anticholinergic drugs like scopolamine). Its specificity for serotonin receptors makes it a valuable option for managing chemotherapy- and radiotherapy-induced nausea and vomiting.
SPD Chemicals offers below Granisetron intermediate, If you’re interested in obtaining further details or making inquiries about the product, you can reach us on sujana@spdchemicals.com. Feel free to contact for more information regarding the purity, pricing, availability, and any other details you may require about the Granisetron intermediate we offer.
No comments yet.